Intraductal therapy for the prevention of breast cancer

Current Opinion in Investigational Drugs

Volumn 11, Issue 6, 2010, Pages 646-652

  Jacobs, Lisa ^a   Sukumar, Saraswati ^a   Stearns, Vered ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Breast cancer; Intraductal therapy; Prevention biomarker; Proliferative lesion; Risk assessment

Indexed keywords

4 HYDROXYTAMOXIFEN; BIOLOGICAL MARKER; CARBOPLATIN; DOXORUBICIN; FLUOROURACIL; METHYLNITROSOUREA;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; DRUG ADMINISTRATION ROUTE; EARLY CANCER; HIGH RISK PATIENT; HUMAN; INTRADUCTAL DRUG ADMINISTRATION; NIPPLE ASPIRATION; NONHUMAN; RAT; REVIEW; RISK ASSESSMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; FEMALE; HUMANS; RISK ASSESSMENT;

EID: 77952898509     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH et al: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med (1999) 340(2):77-84.
2. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 90(18):1371-1378.
3. Waters EA, Cronin KA, Gruubard BI, Han PK, Freedman AN: Prevalence of tamoxifen use for breast cancer chemoprevention among US women. Cancer Epidemiol Biomarkers Prev (2010) 19(2):443-446.
4. Going JJ, Moffat DF: Escaping from Flatland: Clinical and biological aspects of human mammary duct anatomy in three dimensions. J Pathol (2004) 203(1):538-544.
5. Love SM, Barsky SH: Anatomy of the nipple and breast ducts revisited. Cancer (2004) 101(9):1947-1957.
6. Visvanathan K, Lippman SM, Hurley P, Temin S: American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. Gynecol Oncol (2009) 115(1):132-134.
7. Lithgow D, Nyamathi A, Elashoff D, Martinez-Maza O, Covington C: C-reactive protein in nipple aspirate fluid relation to women's health factors. Nurs Res (2006) 55(6):418-425.
8. Mannello F, Tonti GA, Pagliarani S, Benedetti S, Canestrari F, Zhu W, Qin W, Sauter ER: The 8-epimer of prostaglandin F2á, a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer. Int J Cancer (2007) 120(9):1971-1976.
9. Mannello F, Tonti GAM, Medda V, Pederzoli A, Sauter ER: Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer. Cancer Sci (2008) 99(11):2160-2169.
10. Jakupciak JP, Maggrah A, Maragh S, Maki J, Reguly B, Maki K, Wittock R, Robinson K, Wagner PD, Thayer RE, Gehman K et al: Facile whole mitochondrial genome resequencing from nipple aspirate fluid using MitoChip v2.0. BMC Cancer (2008) 8:95.
11. Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK, Kuerer HM: Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotopecoded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer (2006) 6:68.
12. Visvanathan K, Santor D, Ali SZ, Brewster A, Arnold A, Armstrong DK, Davidson NE, Helzlsouer KJ: The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer - A potential tool for breast cancer risk assessment and biomarker evaluation. Cancer Epidemiol Biomarkers Prev (2007) 16(5):950-955.
13. Hünerbein M, Dubowy A, Raubach M, Gebauer B, Topalidis T, Schlag P: Gradient index ductoscopy and intraductal biopsy of intraductal breast lesions. Am J Surg (2007) 194(4):511-514.
14. Sauter ER, Ehya H, Klein-Szanto AJP, Wagner-Mann C, MacGibbon B: Fiberoptic ductoscopy findings in women with and without spontaneous nipple discharge. Cancer (2005) 103(5):914-921.
15. Liu GY, Lu JS, Shen KW, Wu J, Chen CM, Hu Z, Shen ZZ, Zhang TQ, Shao ZM: Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge. Breast Cancer Res Treat (2008) 108(2):271-277.
16. Sauter ER, Wagner-Mann C, Ehya H, Klein-Szanto A: Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings. Cancer Detect Prev (2007) 31(1):50-58.
17. Patil DB, Lankes HA, Nayar R, Masood S, Bryk M, Hou N, Rademaker A, Khan SA: Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women. Breast Cancer Res Treat (2008) 112(2):327-333.
18. Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung B, Davidson NE, Sukumar S: Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet (2001) 357(9265):1335-1336. (Pubitemid 32441534)
19. Lee JS, Fackler MJ, Teo WW, Lee JH, Choi C, Park MH, Yoon JH, Zhang Z, Argani P, Sukumar S: Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis. Cancer Biol Ther (2008) 7(9):1398-1406.
20. Zalles CM, Kimler BF, Simonsen M, Clark JL, Metheny T, Fabian CJ: Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat (2006) 97(2):191-197.
21. Sharma P, Kimler BF, Warner C, Metheny T, Xue Q, Zalles CM, Fabian CJ: Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score. Breast Cancer Res Treat (2006) 100(1):71-76.
22. Bartels PH, Fabian CJ, Kimler BF, Ranger-Moore JR, Frank DH, Yozwiak ML, Alberts DS: Karyometry of breast epithelial cells acquired by random periareolar fine needle aspiration in women at high risk for breast cancer. Anal Quant Cytol Histol (2007) 29(2):63-70.
23. Khan QJ, Kimler BF, Clark J, Metheny T, Zalles CM, Fabian CJ: Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev (2005) 14(4):786-789.
24. Bushnaq ZI, Ashfaq R, Leitch AM, Euhus D: Patient variables that predict atypical cytology by nipple duct lavage. Cancer (2007) 109(7):1247-1254.
25. Baltzell KA, Moghadassi M, Rice T, Sison JD, Wrensch M: Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: A historic prospective study. BMC Cancer (2008) 8:75.
26. Suijkerbuijk KP, van der Wall E, Vooijs M, van Diest PJ: Molecular analysis of nipple fluid for breast cancer screening. Pathobiology (2008) 75(2):149-152.
27. Euhus DM, Bu D, Ashfaq R, Xie XJ, Bian A, Leitch AM, Lewis CM: Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 16(9):1812-1821.
28. Bean GR, Ibarra Drendall C, Goldenberg VK, Baker JC Jr, Troch MM, Paisie C, Wilke LG, Yee L, Marcom PK, Kimler BF, Fabian CJ et al: Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 16(1):50-56.
29. Petroff BK, Phillips TA, Kimler BF, Fabian CJ: Detection of biomarker gene expression by real-time polymerase chain reaction using amplified ribonucleic acids from formalin-fixed random periareolar fine needle aspirates of human breast tissue. Anal Quant Cytol Histol (2006) 28(5):297-302.
30. Li J, Zhao J, Yu X, Lange J, Kuerer H, Krishnamurthy S, Schilling E, Khan SA, Sukumar S, Chan DW: Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res (2005) 11(23):8312-8320.
31. Mannello F, Medda V, Tonti GA: Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients. Expert Rev Proteomics (2009) 6(1):43-60.
32. Mendrinos S, Nolen JD, Styblo T, Carlson G, Pohl J, Lewis M, Ritchie J: Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry. Cancer (2005) 105(3):178-183.
33. Sneige N, Liu B, Yin G, Gong Y, Arun BK: Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in breast fine-needle aspiration specimens from women at high risk for breast cancer. Mod Pathol (2006) 19(5):622-629.
34. Goulet RJ, Badve S, Brannon-Peppas L, Rouch D, Huntley C, Storniolo AM: Pilot trial assessing the feasibility of intra-ductal delivery of epirubicin (epi)-containing nanoparticles (NP) via InDuct@ Breast Microcatheter (IDBM). Proc Am Society Clin Oncol (2004) 22(14 Suppl):Abs 828.
35. Murata S, Kominsky SL, Vali M, Zhang Z, Garrett-Mayer E, Korz D, Huso D, Baker SD, Barber J, Jaffee E, Reilly RT et al: Ductal access for prevention and therapy of mammary tumors. Cancer Res (2006) 66(2):638-645.